News

10 Jun 2021
대한소아감염학회, 소아 잠복결핵에 대한 “Pediatrics LTBI Advisory Board Meeting” 성료


READ MORE

18 May 2021
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test is Used in the UK COVID-19 Human Challenge Study to Investigate the T Cell Response to SARS-CoV-2 Infection

READ MORE

11 May 2021
Oxford Immunotec’s T-SPOT.COVID Test is Used in the COV-AD Clinical Study to Investigate the Immunological Response to SARS-CoV-2 Infection in Patients with Primary and Secondary Antibody Deficiency

READ MORE

29 Apr 2021
Oxford Immunotec’s T-SPOT^® Discovery SARS-CoV-2 Test Used in DIRECT Study to Investigate the T Cell Response and COVID Vaccination in Ethnic Minority Groups

READ MORE

27 Apr 2021
Oxford Immunotec’s T-SPOT^® Discovery SARS-CoV-2 Test is Used in UK Com-COV Clinical Trial to Investigate the T Cell Response in Different Combinations of Approved COVID-19 Vaccines for the First and Second Doses

READ MORE

04 Mar 2021
Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT^®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection


READ MORE